• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » QuintilesIMS, Salesforce partner—from molecule to market

QuintilesIMS, Salesforce partner—from molecule to market

April 25, 2017
CenterWatch Staff

QuintilesIMS, a provider of information, technology services and contract research to the life sciences industry, announced an alliance with Salesforce, a CRM company and Intelligent Customer Success Platform, to offer life sciences companies new capabilities to move treatments more efficiently and effectively, from molecule to market.

As part of the alliance, QuintilesIMS is building new solutions on the Salesforce Platform, taking advantage of built-in cloud, mobile, social and artificial intelligence (AI) capabilities. These solutions—in addition to other products QuintilesIMS builds on the Salesforce Marketing Cloud—will help life science companies better manage clinical trials, accelerate patient recruitment, improve efficiency and effectiveness of marketing activities, as well as achieve other key commercial objectives as they bring new therapies to market and beyond.

“We are thrilled to align with QuintilesIMS to digitally transform the important work of life sciences companies together,” said Keith Block, vice chairman, president and COO, Salesforce. “Building on the Salesforce Intelligent Customer Success Platform, QuintilesIMS will create solutions that empower life sciences firms to collaborate with providers and patients, in smarter and more predictive ways, throughout the clinical life cycle.”

“This Salesforce collaboration furthers our strategy of building our solutions on a foundation of intelligent, technology-standard platforms. Using this approach, as well as continuous updates provided by the platform providers, we can better focus on our areas of differentiation, which deliver the greatest value and benefit to our customers,” said Kevin Knightly, president, Information & Technology Solutions, QuintilesIMS. “We believe this alliance with Salesforce has transformative potential for the life sciences industry as it will better equip and enable our customers to meet the clinical-to-commercial challenges they face as they move healthcare forward.”

While terms of the agreement have not been disclosed, it is a multi-year venture that will operate on a global scale.

“The future of healthcare is at stake in a digital world. Patient success requires co-innovation and co-creation among industry leaders,” said R "Ray" Wang, principal analyst and CEO, Constellation Research. “Only with this close level of partnership can true innovation emerge to transform patient outcomes.”

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing